期刊论文详细信息
Frontiers in Medicine
D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis
Mariano Bernardo1  Luigi Atripaldi1  Silvia Leonardi1  Vittorio Attanasio2  Carlo Tascini2  Carolina Rescigno2  Francesco Sbrana3  Andrea Ripoli3  Emanuela Sozio4  Roberto Andreini6  Simone Meini6  Bruno Viaggi7  Giacomo Bertolino8  Carlo Pallotto9 
[1] Central Laboratory, Azienda Ospedaliera dei Colli, Naples, Italy;First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Naples, Italy;Fondazione Toscana Gabriele Monasterio, Pisa, Italy;Infectious Disease Unit, Department of Medicine, University of Udine, Udine, Italy;Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda Unità Sanitaria Locale Toscana Centro, Florence, Italy;Internal Medicine Unit, Felice Lotti Hospital of Pontedera, Azienda Unità Sanitaria Locale Toscana Nord-Ovest, Pisa, Italy;Neuro Intensive Care Unit, Department of Anesthesiology, Careggi University Hospital, Florence, Italy;Pharmaceutical Department, Ospedale di Sassuolo, Modena, Italy;Section of Infectious Diseases, Department of Medicine, University of Perugia, Perugia, Italy;
关键词: D-dimer;    biomarker;    sepsis;    meningitis;    Streptococcus pneumoniae;    Neisseria meningitidis;   
DOI  :  10.3389/fmed.2021.627830
来源: DOAJ
【 摘 要 】

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection; no current clinical measure adequately reflects the concept of dysregulated response. Coagulation plays a pivotal role in the normal response to pathogens (immunothrombosis), thus the evolution toward sepsis-induced coagulopathy could be individuate through coagulation/fibrinolysis-related biomarkers. We focused on the role of D-dimer assessed within 24 h after admission in predicting clinical outcomes in a cohort of 270 patients hospitalized in a 79 months period for meningitis and/or bloodstream infections due to Streptococcus pneumoniae (n = 162) or Neisseria meningitidis (n = 108). Comparisons were performed with unpaired t-test, Mann-Whitney-test or chi-squared-test with continuity correction, as appropriate, and multivariable logistic regression analysis was performed with Bayesian model averaging. In-hospital mortality was 14.8% for the overall population, significantly higher in S. pneumoniae than in N. meningitidis patients: 19.1 vs. 8.3%, respectively (p = 0.014). At univariable logistic regression analysis the following variables were significantly associated with in-hospital mortality: pneumococcal etiology, female sex, age, ICU admission, SOFA score, septic shock, MODS, and D-dimer levels. At multivariable analysis D-dimer showed an effect only in N. meningitidis subgroup: as 500 ng/mL of D-dimer increased, the probability of unfavorable outcome increased on average by 4%. Median D-dimer was significantly higher in N. meningitidis than in S. pneumoniae patients (1,314 vs. 1,055 ng/mL, p = 0.009). For N. meningitidis in-hospital mortality was 0% for D-dimer <500 ng/mL, very low (3.5%) for D-dimer <7,000 ng/mL, and increased to 26.1% for D-dimer >7,000 ng/mL. Kaplan-Meier analysis of in-hospital mortality showed for N. meningitidis infections a statistically significant difference for D-dimer >7,000 ng/mL compared to values <500 ng/mL (p = 0.021) and 500–3,000 ng/mL (p = 0.002). For S. pneumoniae the mortality risk resulted always high, over 10%, irrespective by D-dimer values. In conclusion, D-dimer is rapid to be obtained, at low cost and available everywhere, and can help stratify the risk of in-hospital mortality and complications in patients with invasive infections due to N. meningitidis: D-dimer <500 ng/mL excludes any further complications, and a cut-off of 7,000 ng/mL seems able to predict a significantly increased mortality risk from much <10% to over 25%.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次